Similar Items: Adjusting for truncated study duration in recurrent event analysis: A weighting approach for clinical trials
- Correction: Role of weight-adjusted waist circumference index and non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio in prediabetes risk: A mediation analysis
- Using GDACS to anticipate clinical and operational burden after earthquakes: A global event-level analysis (2020–2024)
- Disproportionality analysis of fondaparinux associated adverse events based on the FDA adverse event reporting system
- Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG)
- Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system
- Exploring adverse events associated with vosoritide monotherapy: Insights from the FDA Adverse Event Reporting System